| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-06 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-05 |
| mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-05 |